Clinical studies recruiting near Reggio Emilia

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Identifying Genetic Targets in Gynecological Tumors
Phase N/A · Azienda USL IRCCS di Reggio Emilia · Azienda USL Reggio Emilia - IRCCS · NCT07169396 Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Phase 3 · Ausl Di Reggio Emilia - Arcispedale Santa Maria Nuova, Irccs · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT04168502 Subendocardial Viability Ratio in Hypertension
Phase N/A · Medicina II Cardiovascolare, AUSL-IRCCS di Reggio Emilia · Istituto Auxologico Italiano · NCT06309511 A Master Protocol Empowering Mechanobiology Translation Research in Breast Cancer
Phase N/A · Azienda U.S.L. - IRCCS di Reggio Emilia · IFOM ETS - The AIRC Institute of Molecular Oncology · NCT04625023 Study on the Incidence of Malignant Neoplasms in Patients With Parkinson's Disease and Heterozygous Mutation of the GBA
Phase N/A · Azienda USL IRCCS di Reggio Emilia · Azienda USL Reggio Emilia - IRCCS · NCT06814431 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Azienda Unita Sanitaria Locale di Reggio Emilia · Loxo Oncology, Inc. · NCT05254743 Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal
Phase N/A · AUSL IRCCS di Reggio Emilia, Arcispedale S. Maria Nuova · International Extranodal Lymphoma Study Group (IELSG) · NCT05700149 Multicenter Retrospective Observational Study of Relapsed Diffuse Large B-Cell Lymphoma Presenting as Indolent Lymphoma
Phase N/A · Azienda USL IRCCS di Reggio Emilia · Azienda USL Reggio Emilia - IRCCS · NCT06822829 HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT
NA · Research and EBP Unit, Azienda USL-IRCCS di Reggio Emilia · Azienda USL Reggio Emilia - IRCCS · NCT07579065 Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
Phase 3 · Reggio Emilia - AO Santa Maria Nuova · Fondazione Italiana Linfomi - ETS · NCT04442412 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · Arcispedale Santa Maria Nuova Azienda Ospedaliera di Reggio · Sanofi · NCT07290803 Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
Phase N/A · IRCCS Santa Maria Nuova Viale Risorgimento, 80, 42123 Reggio · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06806579 Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Park
Phase N/A · AUSL di Reggio Emilia - Arcispedale Santa Maria Nuova /ID# 2 · AbbVie · NCT06965374 Restoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Priming Followe
Phase 2 · Azienda U.S.L. - IRCCS di Reggio Emilia · IFOM ETS - The AIRC Institute of Molecular Oncology · NCT05582538 A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
Phase 2 · Azienda USL-IRCCS di Reggio Emilia - Presidio ospedaliero pr · Ipsen · NCT06937931 Factors Associated With Health-related Quality of Life and Social Participation of Patients With Multiple Myeloma and Th
Phase N/A · Azienda Unità Sanitaria Locale Reggio Emilia - IRCCS · Azienda USL Reggio Emilia - IRCCS · NCT07014865 OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Phase 3 · Clinical Trial Site · Olema Pharmaceuticals, Inc. · NCT06016738 Endoscopic Resection of Gastrointestinal Neoplasms
Phase N/A · IRCCS-AUSL Reggio Emilia · Azienda USL Reggio Emilia - IRCCS · NCT04780256 A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based
Phase 2 · Azienda USL IRCCS Di Reggio Emilia · North Eastern German Society of Gynaecological Oncology · NCT05460000 Prevention ICONA Dedicated Ensemble
Phase N/A · Azienda Ospedaliera Arcispedale Santa Maria Nuova - U.O. Mal · Fondazione ICONA · NCT07186244 Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer
Phase 3 · Azienda USL IRCCS di Reggio Emilia · University of Campania Luigi Vanvitelli · NCT07389265 National Database of Bone Metastases
Phase N/A · IRCCS Arcispedale S. Maria Nuova - A.O. Reggio Emilia · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRS · NCT06367491 Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
Phase N/A · Azienda USL IRCCS di Reggio Emilia · Azienda USL Reggio Emilia - IRCCS · NCT06822855 Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Phase 3 · Azienda USL IRCCS di Reggio Emilia · Italfarmaco · NCT06093672 Integrated Short-Term Palliative Rehabilitation in Incurable Cancer
NA · AUSL di Reggio Emilia · King's College London · NCT05984797 The Italian Registry of Malnutrition in Oncology
Phase N/A · AUSL IRCCS Reggio-Emilia · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06337019 The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease
NA · AziendaUSL IRCCS Reggio Emilia · Azienda USL Reggio Emilia - IRCCS · NCT06795815 Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
Phase 3 · Azienda USL IRCCS Di Reggio Emilia - Maria Nuova · European Organisation for Research and Treatment of Cancer - · NCT05512364 Perspectives of Italian Employers Regarding the Return to Work Process of Employees Who Received a Cancer Diagnosis: a Q
Phase N/A · Azienda USL IRCCS di Reggio Emilia · Azienda USL Reggio Emilia - IRCCS · NCT06994182 Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
Phase 2 · Acesion Pharma · NCT07267949

Look up another city

Look up another condition